shortagewatch

Home / Nervous system / Codeine, Combinations excl. Psycholeptics

ATC N02AA59 · Natural Opium Alkaloids

Codeine, Combinations excl. Psycholeptics shortage

As of 2 Nov 2026, Codeine, Combinations excl. Psycholeptics has a reported shortage in 1 of the 16 countries we track (Canada), covering 5 products from 2 companies.

Countries1/16
Products5packs or presentations
Companies22 listed
Short since1 Mar 201313.7 years ago
Earliest returnnot givencompany estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada5 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage

Timeline

Canada
20222023202420252026METHOXISAL-C 1/2 (100)METHOXISAL-C 1/2 (100)METHOXISAL-C 1/2 (24)METHOXISAL-C 1/2 (24)METHOXISAL-C 1/4 (24)METHOXISAL-C 1/4 (24)METHOXISAL-C 1/8 (18)METHOXISAL-C 1/8 (18)ROBAXISAL C 1/2 (250)ROBAXISAL C 1/2 (250)today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Teva4 TEVAGSK1 GSK

Listed: Teva TEVA · NYSE / TASE, GSK GSK · LSE

Compared with similar medicines

ATC group N02AA · Natural Opium Alkaloids
Morphine8/16Oxycodone6/16Hydromorphone5/16Dihydrocodeine3/16Oxycodone and Naloxone2/16Codeine, Combinations excl. Psycholeptics1/16

Affected products

CountryProductCompanySinceExpected backReason
CAMETHOXISAL-C 1/2 (100)TEVA CANADA LIMITED1 Mar 2013not givenManufacturing problem
Requirements related to complying with good manufacturing practices
CAMETHOXISAL-C 1/2 (24)TEVA CANADA LIMITED1 Dec 2013not givenManufacturing problem
Requirements related to complying with good manufacturing practices
CAMETHOXISAL-C 1/4 (24)TEVA CANADA LIMITED1 Dec 2013not givenManufacturing problem
Requirements related to complying with good manufacturing practices
CAMETHOXISAL-C 1/8 (18)TEVA CANADA LIMITED1 Dec 2013not givenManufacturing problem
Requirements related to complying with good manufacturing practices
CAROBAXISAL C 1/2 (250)GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC5 Jul 2021not givenManufacturing problem
Disruption of the manufacture of the drug

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.